A general assessment of the safety of HMG CoA reductase inhibitors (statins).

Current atherosclerosis reports

Volumn 4, Issue 1, 2002, Pages 34-41

  Black, Donald M ^a  

^a Pharmaceutical Product Development   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

CLINICAL TRIAL; DRUG COMBINATION; DRUG INTERACTION; HUMAN; HYPERCHOLESTEROLEMIA; REVIEW; SAFETY;

CLINICAL TRIALS; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; SAFETY;

EID: 0002472086     PISSN: 15233804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11883-002-0060-0     Document Type: Review

References (33)